Sippican Capital Advisors Acquires 2,937 Shares of Select Medical Holdings Co. (NYSE:SEM)

Sippican Capital Advisors grew its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 30.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,442 shares of the health services provider’s stock after buying an additional 2,937 shares during the period. Sippican Capital Advisors’ holdings in Select Medical were worth $434,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in SEM. Allspring Global Investments Holdings LLC increased its position in Select Medical by 6.6% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 6,563 shares of the health services provider’s stock worth $198,000 after buying an additional 405 shares during the period. BNP Paribas Financial Markets increased its position in Select Medical by 26.1% during the 1st quarter. BNP Paribas Financial Markets now owns 55,543 shares of the health services provider’s stock worth $1,675,000 after buying an additional 11,507 shares during the period. Capstone Investment Advisors LLC bought a new position in Select Medical during the 1st quarter worth $690,000. Fidelis Capital Partners LLC acquired a new stake in shares of Select Medical during the 1st quarter worth $47,000. Finally, Essex Investment Management Co. LLC grew its holdings in shares of Select Medical by 16.9% during the 1st quarter. Essex Investment Management Co. LLC now owns 156,574 shares of the health services provider’s stock worth $4,721,000 after purchasing an additional 22,674 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on SEM shares. Benchmark reissued a “buy” rating and set a $48.00 target price on shares of Select Medical in a report on Friday, September 6th. Bank of America started coverage on Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 target price on the stock. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $39.00.

Select Medical Price Performance

NYSE:SEM traded down $0.07 during trading hours on Thursday, hitting $32.78. The company’s stock had a trading volume of 7,844 shares, compared to its average volume of 593,384. The stock has a fifty day simple moving average of $34.30 and a 200-day simple moving average of $33.93. The company has a market capitalization of $4.26 billion, a P/E ratio of 15.71, a PEG ratio of 1.96 and a beta of 1.41. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 1.09. Select Medical Holdings Co. has a twelve month low of $21.28 and a twelve month high of $40.50.

Select Medical (NYSE:SEM) last released its quarterly earnings data on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.61 by ($0.01). Select Medical had a net margin of 3.91% and a return on equity of 17.50%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same period last year, the business earned $0.61 earnings per share. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. On average, analysts anticipate that Select Medical Holdings Co. will post 2.03 EPS for the current fiscal year.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.